SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
CFC12
Lv4
468 积分
2023-11-04 加入
最近求助
最近应助
互助留言
Randomized Phase II Study of Gemcitabine With or Without ATR Inhibitor Berzosertib in Platinum-Resistant Ovarian Cancer: Final Overall Survival and Biomarker Analyses
10天前
已完结
The antibody–drug conjugate landscape
12天前
已关闭
The antibody–drug conjugate landscape
12天前
已关闭
WCN24-2099 BASELINE CHARACTERISTICS OF THE ALIGN TRIAL: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL OF ATRASENTAN IN PATIENTS WITH IGAN
20天前
已完结
Abstract 310: Cadherin-dependent modulation of chemosensitivity in oral tumor progression
21天前
已关闭
104TiP Phase Ib/IIa study of ATR inhibitor tuvusertib + anti-PD-1 cemiplimab in patients with advanced non-squamous (nsq) non-small cell lung cancer (NSCLC) that has progressed on prior anti-PD-(L)1 and platinum-based therapies
1个月前
已完结
Abstract 3124: MRG006A, a novel glypican-3-targeting antibody-drug conjugate, demonstrated potent anti-tumor activity and good safety profile in preclinical studies
1个月前
已关闭
The novel ATR inhibitor M1774 induces replication protein overexpression and broad synergy with DNA-targeted anticancer drugs
1个月前
已完结
Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial
1个月前
已完结
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression
1个月前
已完结
没有进行任何应助
已找到【积分已退回】
21天前
还请重新上传。谢谢
1个月前
标题错误
1个月前
暂时没有上传【积分已退回】
4个月前
暂不查找【积分已退回】
4个月前
DOI错误
5个月前
已找到【积分已退回】
5个月前
是书籍,不是文章。
5个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论